Tradestie Institutional Equity Comparison Engine

CSBR vs OTLK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OTLK Overall Edge

OTLK Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Outlook Therapeutics, Inc. Common Stock (OTLK) driven by superior Valuation, Growth & Margin, Options & Structure while CSBR counters with relative strength in Momentum & Technical. Fundamentally, CSBR trades at 47.0x Forward P/E with -1.5% operating margin (+8.8% YoY revenue) versus OTLK at 2.9x Forward P/E and 4781.8% operating margin (-99.4% YoY). In options structure, CSBR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OTLK sits in BREAKDOWN (55th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner OTLK
CSBR 47.0x vs OTLK 2.9x Fwd P/E
Growth & Margin Winner OTLK
Op Margin -1.5% vs 4781.8% ยท YoY +8.8% vs -99.4%
Momentum & Technical Winner CSBR
1Y -32.8% vs -73.0% ยท 52W Pos 5% vs 10%
Options & Structure Winner OTLK
UNCLASSIFIED (N/A IV) vs BREAKDOWN (55th %ile IV)
CSBR NASDAQ
Champions Oncology, Inc.
Biological Products, (No Disgnostic Substances)
$4.71
+1.18% 1D
Market Cap $64.7M
1M Return -1.77%
1Y Return -32.79%
Forward P/E 47.0x
Unified AI Score
42.9 / 100 HOLD
Tech 46.0 Fund 47.0 Flow 50.0 Mom 54.0
OTLK NASDAQ
Outlook Therapeutics, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.40
-4.04% 1D
Market Cap $107.1M
1M Return -18.82%
1Y Return -73.04%
Forward P/E 2.9x
Unified AI Score
48.6 / 100 HOLD
Tech 33.0 Fund 48.0 Flow 71.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CSBR -32.79% OTLK -73.04% Spread: +40.09 pp (CSBR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CSBR TTM Op. Margin: -1.5% OTLK TTM Op. Margin: 4781.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CSBR vs OTLK. Trailing 12-month operating profitability (CSBR -1.5% vs OTLK 4781.8%) and valuation multiples (CSBR 47.0x vs OTLK 2.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CSBR (2) vs OTLK (8)
Institutional Metric CSBR OTLK Criterion Row Winner
Market Capitalization Scale $64.7M $107.1M Larger Scale OTLK
Trailing P/E Ratio Valuation 22.9x 2.9x Lower Multiple OTLK
Forward P/E Ratio Valuation 47.0x 2.9x Lower Multiple OTLK
Revenue Growth (YoY) Growth +8.8% -99.4% Higher Growth CSBR
Operating Margin (TTM) Profitability -1.5% 4781.8% Higher Margin OTLK
Net Profit Margin Profitability -1.9% 0.0% Higher Margin OTLK
Return on Equity (ROE) Capital Efficiency -28.4% -3.6% Higher ROE OTLK
52-Week Range Position Momentum 5% ($5โ€“$8) 10% ($0โ€“$3) Stronger Trend OTLK
Beta / 30D Volatility Risk Regime 0.36ฮฒ ยท 24% Vol 1.47ฮฒ ยท 79% Vol Lower Realized Risk CSBR
Unified Institutional Score Composite Signal 42.9 / 100 (HOLD) 48.6 / 100 (HOLD) Higher Composite OTLK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CSBR vs OTLK Buy Guide
CSBR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CSBR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OTLK BREAKDOWN
103d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 55th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live OTLK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CSBR nor OTLK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.